MedTrace Logo

CIRculating CANcer MAster-Protocol

NCT05089747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2023-07-24

No results posted yet for this study

Summary

This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease

Conditions

  • Adult With Solid Cancer

Interventions

BIOLOGICAL

Blood sampling for biomarker analysis (microRNA, circulating DNA…)

From one to four blood samplings: at diagnosis, after the first cycle of treatment, end of treatment, progressive disease (or end of study).

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-05
Primary Completion
2047-12-01
Completion
2047-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05089747 on ClinicalTrials.gov